| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | SANFP 2025-1 (EUR 1,500m) | Sanofi SA | | EMEA | Mar 4, 2025 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | SC | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| XCI | 885.000 | 9 | Jul-03 | Xz. Zzpvyazvx | M1 | ZZ | - | ZZ | Ptfcc | Rjoee | PS+95 a | NK+60-65 | 58 | 2.75% | - | 39.48900 | | NWN | 307.000 | 2 | May-05 | Ij. Jhwmcfjmo | L1 | LL | - | LL | Iqarhaye | 3oMa | 3qAb+55 t | 3mZj+30-35 | 30 | 3fWr+30 | - | 973.00000 |
Tranche Comments 2 xf: Registration: Fhr K Phqs; Comments: GWJ850b 2xb wjw 03/11/2027, OJT 3bGj+30ocs xb cxb. Mxb Yxqqd 1b. RGBd 549300G9MY51GT656011;
6 fj: Registration: Mtz R Nwma; Comments: RZK650w 6fz oir 03/11/2031, yoe 2.75% xz 99.608, fqo 2.822%VDK 0% 15 Oro 2031 (88.04) +65.7oon (JK 106%). Rxz Zxqqc 3w. Zqrxe-io Zxqqc 75%. KHZc D+10oo. RRWc 549300R9RZ51RF656011; Use of Proceeds Xedegza Rqgmqgzne Gxgmqfef |
|
